Melanoma Journal Articles for May 2018
Cancer Discovery
Dual MAPK/CDK Targeting in Melanoma: New Approaches, New Challenges
Ryan J. Sullivan
DOI: 10.1158/2159-8290.CD-18-0224 Published May 2018
_________________________________________________________________
BMC
Vemurafenib in Chinese patients with BRAFV600mutation–positive unresectable or metastatic melanoma: an open-label, multicenter phase I study
Lu Si†, Xiaoshi Zhang†, Zhen Xu, Qiudi Jiang, Lilian Bu, Xuan Wang, Lili Mao, Weijiang Zhang, Nicole Richie and Jun Guo
BMC Cancer201818:520
https://doi.org/10.1186/s12885-018-4336-3
Received: 14 November 2016
Accepted: 12 March 2018
Published: 3 May 2018
______________________________________________________
Dove Press
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
Authors Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB
Received 8 September 2017
Accepted for publication 27 January 2018
Published 9 May 2018 Volume 2018:10 Pages 537—548
DOI https://doi.org/10.2147/CLEP.S151246
________________________________________________________
Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas
Alexandra Giantini Larsen, BS Benjamin L Grannan, MD Christine K Lee, MD, PhDMatthew J Koch, MD Erik A Williams, MD Matthew P Frosch, MD, PhDDaniel P Cahill, MD, PhD
Journal of Neuropathology & Experimental Neurology, nly029, https://doi.org/10.1093/jnen/nly029
_____________________________________________________________________________
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Carl Morrison†, Sarabjot Pabla†, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Devin Dressman, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Felicia L. Lenzo, Angela Omilian, Wiam Bshara, Matthew Zibelman, Pooja Ghatalia, Konstantin Dragnev, Keisuke Shirai, Katherine G. Madden, Laura J. Tafe, Neel Shah, Deepa Kasuganti, Luis de la Cruz-Merino, Isabel Araujo, Yvonne Saenger, Margaret Bogardus, Miguel Villalona-Calero, Zuanel Diaz, Roger Day, Marcia Eisenberg, Steven M. Anderson, Igor Puzanov, Lorenzo Galluzzi, Mark Gardner and Marc S. Ernstoff
Journal for ImmunoTherapy of Cancer20186:32
https://doi.org/10.1186/s40425-018-0344-8
Received: 13 February 2018
Accepted: 20 April 2018
Published: 9 May 2018
___________________________________________________________
Improving the Propranolol Treatment of Melanoma—Reply
Silvia Benemei, MD1; Pierangelo Geppetti, MD1; Vincenzo De Giorgi, MD2
JAMA Oncol. Published online May 10, 2018.
doi:10.1001/jamaoncol.2018.0619
______________________________________________________________
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
Michele Guida, Stefania Tommasi, Sabino Strippoli, Maria Iole Natalicchio, Simona De Summa, Rosamaria Pinto, Antonio Cramarossa, Anna Albano, Salvatore Pisconti, Michele Aieta, Ruggiero Ridolfi, Amalia Azzariti, Gabriella Guida, Vito Lorusso and Giusepe Colucci
BMC Cancer201818:552
https://doi.org/10.1186/s12885-018-4479-2
Received: 8 July 2016
Accepted: 2 May 2018
Published: 10 May 2018
_______________________________________________________________________
Dove Press
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project
Authors Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S
Received 26 October 2017
Accepted for publication 12 February 2018
Published 14 May 2018 Volume 2018:10 Pages 1143—1154
DOI https://doi.org/10.2147/CMAR.S155283
________________________________________________________________________
PRIMARY MALIGNANT MELANOMA OF THE SPINAL CORD
ARTHUR B. KING, M.D.; JOHN W. CHAMBERS, M.D.; JAMES GAREY, M.D.
AMA Arch NeurPsych. 1952;68(2):266-275. doi:10.1001/archneurpsyc.1952.02320200104012
_____________________________________________________________________
Cancer Research
NK cell editing mediates Epithelial to Mesenchymal Transition via phenotypic and proteomic changes in melanoma cell lines
Leticia Huergo Zapico, Monica Parodi, Claudia Cantoni, Chiara Lavarello, Juan L Fernández-Martínez, Andrea Petretto, Enrique J DeAndrés-Galiana, Mirna Balsamo, Alejandro López-Soto, Gabriella Pietra, Mattia Bugatti, Enrico Munari, Marcella Marconi, Maria Cristina Mingari, William Vermi, Lorenzo Moretta, Segundo Gonzalez and Massimo Vitale
DOI: 10.1158/0008-5472.CAN-17-1891
________________________________________________________________
Dove Press
Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
Authors Brewington BY, Shao YF, Davidorf FH, Cebulla CM
Received 9 August 2017
Accepted for publication 20 February 2018
Published 17 May 2018 Volume 2018:12 Pages 925—934
DOI https://doi.org/10.2147/OPTH.S129645
_________________________________________________________________
Clinical Cancer Research
Playing the melanoma endgame
Jessica L.F. Teh and Andrew E. Aplin
DOI: 10.1158/1078-0432.CCR-18-0989
Accepted May 10, 2018
_____________________________________________________________________
OncoImmunology
Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target
Muhammad Zaeem Noman,Jerome Paggetti,Etienne Moussay,Guy Berchem &Bassam Janji
Article: e1452583 | Received 08 Mar 2018, Accepted 10 Mar 2018, Accepted author version posted online: 15 Mar 2018, Published online: 25 Apr 2018
https://doi.org/10.1080/2162402X.2018.1452583
____________________________________________________________________
Journal of Oncology Practice
Management of In-Transit Melanoma: We Need Some High-Quality Data
DOI: 10.1200/JOP.18.00215
Journal of Oncology Practice 14, no. 5 (May 1 2018) 302-303.
______________________________________________
Advances in the systemic treatment of melanoma brain metastases
I C Glitza Oliva G Schvartsman H Tawbi
Annals of Oncology, mdy185, https://doi.org/10.1093/annonc/mdy185
Published: 22 May 2018
________________________________________________________________
Cutaneous Eruption Secondary to Immunotherapy for Metastatic Melanoma Limited to Sites of Locoregional Melanoma Metastases A Possible Variant of Locus Minoris Resistentiae
Marie Donaldson, BA1; Joshua L. Owen, MD, PhD1; Jennifer N. Choi, MD1,2
JAMA Dermatol. Published online May 23, 2018. doi:10.1001/jamadermatol.2018.0654
_____________________________________________________
Biochimie
Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers
Dorota Hoja-?ukowicza, , , Sabina Szweda, , Piotr Laidlerb, , Anna Lity?skaa,
https://doi.org/10.1016/j.biochi.2018.05.010
_____________________________________________________________
Journal of Molecular Biology
Genome-Wide RNAi Screen Identify Melanoma-Associated Antigen Mageb3 Involved in X Chromosome Inactivation
Wei Li1, †, Ru Hong1, †, Lan-Tian Lai1, Qiman Dong3, Peiling Ni3, Rosi Chelliah1, Mehnaz Huq1, Siti Nadirah Binte Ismail1, Udita Chandola1, Zhiwei Ang1, Bingqing Lin1, Xin Chen2, Lingyi Chen3, , ,
https://doi.org/10.1016/j.jmb.2018.05.031
___________________________________________________________
Molecular Pharmaceutics
In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma
Abner A. Murray, Chao Wang, Steven Fiering, and Nicole F. Steinmetz
DOI: 10.1021/acs.molpharmaceut.8b00316
Publication Date (Web): May 25, 2018
__________________________________________________________
Cancer Letters
Pinocembrin induces ER stress mediated apoptosis and suppresses autophagy in melanoma cells
Yufei Zhenga, Kai Wangb, Yuqi Wua, Yifan Chena, Xi Chena, Chenyue W. Huc, Fuliang Hua, ,
https://doi.org/10.1016/j.canlet.2018.05.026
________________________________________________________________
Acta Physiologica
Cutaneous pH landscape as a facilitator of melanoma initiation and progression
Alexander Koch and Albrecht Schwab
First published: 26 May 2018
https://doi.org/10.1111/apha.13105
____________________________________________________________
Advanced Functional Materials
Targeted Nanoparticle?Mediated Gene Therapy Mimics Oncolytic Virus for Effective Melanoma Treatment
Li Luo, Yuping Yang, Ting Du, Tianyi Kang, Meimei Xiong, Hao Cheng, Yu Liu, Yujiao Wu, Yang Li, Yuwen Chen, Qianqian Zhang, Xuan Liu, Xiawei Wei, Peng Mi, Zhigang She, et al.
First published: 28 May 2018
https://doi.org/10.1002/adfm.201800173
__________________________________________________________________________
Annals of Oncology
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists
H A Haenssle C Fink R Schneiderbauer F Toberer T Buhl A Blum A Kalloo Hadj Hassen L Thomas A Enk … et.al.
Annals of Oncology, mdy166, https://doi.org/10.1093/annonc/mdy166
Published:28 May 2018
__________________________________________________________________
Science Translational Medicine
Ironing out dedifferentiation in melanoma
Tríona Ní Chonghaile
Science Translational Medicine 30 May 2018:
Vol. 10, Issue 443, eaau0461
DOI: 10.1126/scitranslmed.aau0461
______________________________________________________________________
Clinical Cancer Research
Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome
Marie-Andrée Forget, Cara Haymaker, Kenneth R. Hess, Yuzhong Jeff Meng, Caitlin Creasy, Tatiana V. Karpinets, Orenthial J. Fulbright, Jason Roszik, Scott E. Woodman, Young Uk Kim, Donastas Sakellariou-Thompson, Ankit Bhatta, Arely Wahl, Esteban Flores, Shawne T. Thorsen, Rene J. Tavera, Renjith Ramachandran, Audrey M. Gonzalez, Christopher Toth, Seth Wardell, Rahmatu Mansaray, Vruti Patel, Destiny Joy Carpio, Carol S. Vaughn, Chantell M. Farinas, Portia G. Velasquez, Wen-Jen Hwu, Sapna P. Patel, Michael A. Davies, Adi Diab, Isabella C. Glitza, Hussein Tawbi, Michael K.K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard Royal, J.N. Cormier, Jennifer A. Wargo, Laszlo G. Radvanyi, Carlos A. Torres Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria and Chantale Bernatchez
DOI: 10.1158/1078-0432.CCR-17-3649
_________________________________________________________________
Gilhooley E, McKenna D, “Determination of the impact of melanoma surgical timing on survival using the National Cancer Database”, Journal of the American Academy of Dermatology (2018), doi: 10.1016/j.jaad.2018.03.061.
________________________________________________________________________
Brain Metastases from Primary Tumors, Volume 3
Epidemiology, Biology, and Therapy of Melanoma and Other Cancers
2016, Pages 185–196
Chapter 13 – Patients with Brain Metastases from Melanoma: Treatment with Surgery and Radiotherapy
Michael N. Khoury, Symeon Missios, Nam D. Tran, Peter A. Forsyth
https://doi.org/10.1016/B978-0-12-803508-5.00013-5
__________________________________________________________
Dove Press
Melanoma treatment in review
Authors Domingues B, Lopes JM, Soares P, Pópulo H
Received 30 January 2018
Accepted for publication 16 March 2018
Published 7 June 2018 Volume 2018:7 Pages 35—49
DOI https://doi.org/10.2147/ITT.S134842
___________________________________________________